Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter
22 févr. 2018 08h39 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), announced today that within the first half of Q1-2018 it has set up trials for pathology lab services with 4 times...
Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance
15 févr. 2018 08h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO) announced today its launch of the first lung cancer treatment resistance panel specifically for the critical...
Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter
09 févr. 2018 09h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces preliminary, unaudited revenues for the 4th quarter of 2017 of approximately...
Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale
06 févr. 2018 08h37 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces its entry into the Japanese market with a first order of its ICE-COLD PCR™...
Earth Science Tech, Inc. Achieves Q1 Goal with Expansion of Executive Leadership Team
01 févr. 2018 08h00 HE
|
Earth Science Tech, Inc.
DORAL, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK:ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and...
Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania
22 janv. 2018 08h27 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO), today announced it is collaborating with the cytogenetics laboratory at the University of...
Precipio Appoints New Sales VP to Manage Diagnostics Sales Expansion
16 janv. 2018 08h27 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO) has appointed Douglas Sites to the new position of Vice President of Sales where he will...
Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy
10 janv. 2018 08h27 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced preliminary data from an ongoing study on the impact of academic...
AXIM Biotech Attends Biotech Showcase and J.P. Morgan Healthcare Conferences in San Francisco
10 janv. 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Jan. 10, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov,...
Can-Fite BioPharma Announces Clinical and Corporate Developments for Near-Term Events
22 oct. 2013 15h10 HE
|
Can-Fite BioPharma
PETACH TIKVA, ISRAEL--(Marketwired - Oct 22, 2013) - Can-Fite BioPharma (TASE: CFBI), (OTCQB: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address...